Jefferies 2014 Global Healthcare Conference June 2, 2014
|
|
- Adela Shepherd
- 6 years ago
- Views:
Transcription
1 Jefferies 2014 Global Healthcare Conference June 2, 2014
2 Safe Harbor Provision In accordance with the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as may, could, expect, intend, believe, plan, estimate, forecast, project, anticipate or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the SEC and will be contained in all subsequent periodic filings we make with the SEC. These documents identify, in detail, important risk factors that could cause our actual performance to differ materially from current expectations. Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the cost of shipping our products or other service issues with our third-party shippers; general global macro-economic conditions; disruptions in financial markets; possible volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our international operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from challenges associated with the emergence of potential increased competition by third party online commerce sites; risks from disruption to our information systems; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements. 2
3 Henry Schein Largest Distributor of Health Care Products and Services to Office-based Dental, Animal Health and Medical Practitioners More Than 800,000 Customers # years Nearly 17,000 Employees CAGRs from 1995 to 2013 Net Sales Diluted Earnings Per Share Market Cap 3
4 Henry Schein s Value-Added Market Approach Dental Animal Health Medical Full-service provider of supplies, equipment and services Broadest merchandise product offering High technology equipment and services Exclusive and specialty products Technology and Value-Added Services Wide array of value-added products and services Education Practice management software solutions Leasing and financial services Office design services Practice transition services Corporate and Distribution Services 4
5 Company Objective Our primary objective is to partner with our customers Improve Practice Efficiency Productivity Profitability Allowing our customers to focus on delivering quality care to their patients 5
6 Leading Market Positions Consistent Growth Reliable track record of growth Markets Served #1 Dental distributor Markets Served distributor #1 Animal Health #2 Physician and Alternate Care distributor Fragmented Competitors Small number of large, national competitors Approximately half target markets served by smaller companies that tend to be undercapitalized Recession Resistant Fragmented Customer Base Somewhat elastic with macroeconomic trends More than 800,000 customers; over 1 million practitioners 6
7 Positive Market Trends Positive Demographic Trends Aging population represents increasing need for health care services Global middle class is growing U.S. population continues to become more diverse Focus on Preventative Care Improving access to care Affordable Care Act will lead to more covered individuals Movement of procedures from hospital to physician office Technological Improvements Consolidation of Practitioners in Dental, Animal Health & Medical Prosthetic solutions Software and services Patient communications Equipment and supplies Catering to multiple locations under common management 7
8 Our Global Distribution Network Distribution Centers 9 Core North American Distribution Centers serving Dental and Medical 14 U.S. Distribution Centers serving Animal Health 20 Distribution Centers in Europe serving Dental, Medical and Animal Health 18 Distribution Centers in Australia/New Zealand serving Dental and Animal Health 5 Distribution Centers in Asia/Rest of World serving Dental 75 80% utilization with capacity for growth 66 warehouses worldwide with 4.5 million square feet of warehouse for storage and processing 8
9 Corporate Growth Strategies GO HSIC 9
10 Dental Market Position Only global dental distributor to general practitioners, specialists and laboratories #1 in North America #1 in Europe #1 in Australia/New Zealand Active customers 90% of U.S. dental practices Over 70% of dental labs in North America Over 65% of European dental practices Over 80% of Australia/New Zealand dental practices Multifaceted sales and marketing approach 2,500 dedicated field sales consultants Product specialists, e.g., capital equipment, technology, etc. Telesales Direct marketing 10
11 Dental Market 2013 Henry Schein Global Dental Sales By Geography $5.0B or 52.3% of Net Sales Market Share: North America: 35% to 40% Europe: 20+% Australia/New Zealand: 30% Available Market: $20 billion Market information excludes specialty products, services and precious metals Market Share and Available Market Represent Henry Schein Estimates 11
12 Henry Schein s Dental Offering Merchandise Business Solutions Equipment & Technology Practice Management Software Technical Service Specialty Products CAD-CAM 12
13 Growth Opportunities Geographic expansion Advancing practice management solutions Acceleration of high-technology solutions Continued focus on large group practices Digitalization of prosthetic solutions Greater penetration of specialty markets Key Distribution or Manufacturing Acquisitions Arseus (2014) BioHorizons (2014) Dental Warehouse (2013) Optident (2013) Accord (2012) Ortho Technology (2012) SOGIM (2011) Brasseler USA (2010) Key Technology and Value Added Services Acquisitions Maddox (2013) Exan (2012) 13
14 Dental Specialty Markets Dental Specialties More than $500 million in annual revenue Market Share: 6% Implants High-margin business Traditionally faster growth than core dental market Ability to leverage existing relationships with specialty practitioners General practitioners increasingly performing specialty procedures Available Market: $6.6 billion Market Share: 8% Orthodontics Focus on orthodontic specialist Opportunity to expand product offering Specialist and general practitioner education Endodontics Market Share: 4% Market Share: 20% Up to 25 million root canal treatments performed in U.S. each year General Practitioners perform approximately 80% of root canal treatments in the U.S. U.S. market accounts for approximately 31% of the worldwide endodontic market Aging population retaining more teeth and electing root canal treatments as opposed to extraction will continue to fuel opportunity for growth Available Market is a Henry Schein Estimate 14
15 Animal Health Market Position Only global distributor to veterinarians #1 in North America #1 in Europe #1 in Australia/New Zealand Active customers of Henry Schein 75% of veterinarians in U.S. 70% of veterinarians in Europe 70% of veterinarians in Australia/New Zealand Nearly 400 dedicated field sales consultants Source: Henry Schein Estimates 15
16 Animal Health Market 2013 Henry Schein Global Animal Health Sales By Geography $2.6B or 27.2% of Net Sales Market Share: North America: 35% Europe: 20% Australia/New Zealand: 20% Available Market: $10 billion Sales on U.S. GAAP basis not grossed up for agency sales Market Share and Available Market Represent Henry Schein Estimates 16
17 Growth Opportunities Geographic expansion Advancing technology solutions, including practice management Focus on practice-building products and services Key Distribution Acquisitions Medivet (2014) C&M Vetlink (2012) AUV Veterinary Group (2012) Veterinary Instrumentation (2012) Provet (2011) Butler (2010) Key Technology Acquisitions McAllister/ImproMed (2011) 17
18 Medical Market Position #2 U.S. distributor to primary care physicians and specialists, group practices, physician-owned labs and ambulatory surgery centers U.S. market focus significant growth opportunities Almost 50% of U.S. physician practices are active customers of Henry Schein Select international opportunities Specialization Segmentation 450 dedicated sales consultants Multi-channel capabilities Source: Henry Schein Estimates 18
19 Medical Market 2013 Henry Schein Global Medical Sales By Geography $1.6B or 17.2% of Net Sales U.S. Market Share: High teens % Available Market: $9 to $10 billion Market information excludes certain specialty and oncology pharmaceutical products, software and certain other services Market Share and Available Market Represent Henry Schein Estimates 19
20 Technology & Value-Added Services Market Position Practice Management Solutions Two-thirds of revenue is recurring Technical support E-claims and credit card processing Only practice management software solutions provider servicing dental, animal health and medical practitioners U.S. penetration Over 40% dental practices Over 50% animal health practices Growing physician presence A leader in servicing large practices Direct access to over 65% of dental schools in North America In 14 countries outside the U.S. Synergies with broader distribution business Leveraging R&D, marketing, and technology across business units Technology development for a global business Financial Services Full-service provider of financial services Providing value-add to clients Source: Henry Schein Estimates 20
21 Technology & Value-Added Solutions 2013 Henry Schein Global Technology & Value-Added Services By Geography $320M or 3.3% of Net Sales Key Acquisitions Exan (2012) McAllister/ImproMed (2011) Approximately 13% of Total Company Operating Income 21
22 Financial Performance
23 Growth Since Going Public ($ in millions, except per share data) Compound Annual Growth Rate Net Sales $616.2 $9, % Operating Income $19.3 $ % Operating Margin 3.1% 7.1% 22 bp Net Income¹ $9.1 $ % Diluted EPS¹ $0.34 $ % ¹ From continuing operations and excluding certain non-recurring items 23
24 Full Year 2013 Financial Highlights ($ in millions, except per share data) Growth Sales $8,940.0 $9, % Operating Income¹ $634.2 $ % Operating Margin¹ 7.09% 7.08% (1) bp Net Income 1 $398.6 $ % Diluted EPS 1 $4.44 $ % 2013 Adjusted EPS Exceeded Top of Original Guidance Range of $4.81 to $4.91 by 4 Cents ¹ Excludes certain non-recurring items to provide a more comparable basis for analysis. 24
25 Q Financial Highlights ($ in millions, except per share data) Q Q Growth Sales $2,293.5 $2, % Operating Income $153.6 $ % Operating Margin 6.70% 6.47% (23) bp Net Income 1 $94.2 $ % Diluted EPS 1 $1.06 $ % ¹ Excludes certain non-recurring items to provide a more comparable basis for analysis. 25
26 Diversified Sales in Complementary Markets 2013 Worldwide Sales: $9.6 billion By Product By Geography (29%) 29% Future Sales Sales outside of North America continuing to grow at a faster rate Fragmented markets Large market penetration in North America Geographic expansion 26
27 Sales Highlights 7% Long-Term Financial Model and Goals Goal: Grow 1% to 2% faster than end market growth rates (organic) Result: Sales Growth Internal 1% 3% 5% 5% 4% Acquisition 5% 12% 5% 3% 3% Total Local Currency Sales Growth 6% 15% 11% 7% 7% Foreign Exchange/Other (4%) - % 2% (2%) - % Total Sales Growth 2% 15% 13% 5% 7% As originally reported except as noted 1 Adjusted for extra week in
28 Operating Income and Margin Highlights 7% Long-Term Financial Model and Goals Goal: Continued operating margin expansion Approximately 20 basis points expansion in current environment (on a same store basis) Higher as end markets and sales accelerate Result: (Average Annual Operating Margin 3.1% 7.1% Increase of 22 bp) 28
29 Earnings Highlights Long-Term Financial Model and Goals Goal: High single to low double digit organic EPS growth enhanced by share repurchases and acquisitions Result: EPS $0.34 $4.95 (CAGR of 16%) 29
30 Cash Flow Highlights Long-Term Financial Model and Goals Annual operating cash flow has exceeded net income by nearly $600 million since
31 Cash Return to Shareholders Share Repurchases 31
32 Investing in the Future Goal is to invest $200 to $300 million annually in strategic M&A $400,000 $350,000 Payments Related to Equity Investments and Business Acquisitions, Net of Cash Acquired (in thousands) $353M $300,000 $250,000 $200,000 $150,000 $149M $220M $182M $100,000 $50,000 $ Net of Cash Acquired 32
33 Strong Balance Sheet ($ in millions) Net Debt to Total Capitalization Ratio March 29, 2014 Cash & Equivalents Working Capital Total Assets Total Debt Equity DSO Inventory Turns Net Debt to Total Capitalization Ratio $129.1 $1,263.6 $5,880.1 $ , days 5.6x 19.03% 33
34 Investment Merits Multiple organic and strategic growth opportunities Proven financial track record Operating model goals set the stage for attractive long-term growth Experienced Management Team 34
Safe Harbor Provision
Q2 2016 Safe Harbor Provision Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the "Safe Harbor" provisions of the Private Securities Litigation
More informationNASDAQ: HSIC Q3 2017
NASDAQ: HSIC Q3 2017 Safe Harbor Provision Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the "Safe Harbor" provisions of the Private
More informationNASDAQ: HSIC Q1 2018
NASDAQ: HSIC Q1 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationNASDAQ: HSIC Q3 2018
NASDAQ: HSIC Q3 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationPage 1 of 6 Print Page Close Window Press Release Henry Schein Reports Record Fourth Quarter And Annual Results Q4 EPS up 9.1% to $1.56 Affirms 2015 financial guidance range MELVILLE, N.Y., Feb. 11, 2015
More informationHENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE
HENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE APRIL 23, 2018 Safe Harbor Statement Forward Looking Statements
More informationLOOKING statements. Forward
1 Forward LOOKING statements This presentation contains forward-looking statements regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties.
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION F O RWA R D L O O K I N G S TAT E M E N T S This presentation contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding
More informationIDEXX Laboratories Announces Second Quarter Results
FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit
More informationCFA Society of Minnesota
CFA Society of Minnesota Intellisight 2018 August 15, 2018 John Penshorn Senior Vice President, UnitedHealth Group Mark Flakne Chief Financial Officer, OptumHealth Tim Noel Chief Financial Officer, UnitedHealthcare
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationInvestor Presentation. J.P. Morgan ATI Conference March 14, 2018 New York, NY
Investor Presentation J.P. Morgan ATI Conference March 14, 2018 New York, NY Safe Harbor Statement This Presentation contains or incorporates by reference statements that are not historical in nature and
More informationTENNANT COMPANY. INVESTOR PRESENTATION Second Quarter 2018 REINVENTING HOW THE WORLD CLEANS
INVESTOR PRESENTATION Second Quarter 2018 REINVENTING HOW THE WORLD CLEANS 2 Safe Harbor Statement This presentation contains certain statements that are considered forward-looking statements within the
More informationBERNSTEIN. 34 th Annual Strategic Decisions Conference. David Wichmann, CEO May 31, 2018
BERNSTEIN 34 th Annual Strategic Decisions Conference David Wichmann, CEO May 31, 2018 2018 UnitedHealth Group. All Rights Reserved. UnitedHealth Group is a registered trademark with the U.S. Patent and
More informationTENNANT COMPANY. INVESTOR PRESENTATION Third Quarter 2018 REINVENTING HOW THE WORLD CLEANS
INVESTOR PRESENTATION Third Quarter 2018 REINVENTING HOW THE WORLD CLEANS 2 Safe Harbor Statement This presentation contains certain statements that are considered forward-looking statements within the
More informationInvestor Presentation. February 2018
Investor Presentation February 2018 1 Forward Looking Statements Important Information About Littelfuse, Inc. This presentation does not constitute or form part of, and should not be construed as, an offer
More informationQ2 Fiscal 2017 Earnings Commentary
Q2 Fiscal 2017 Earnings Commentary August 31, 2017 The financial measures discussed below include both GAAP and adjusted non-gaap financial measures. In connection with the restructuring of its ivivva
More information2009 UBS Healthcare Services Conference
2009 UBS Healthcare Services Conference February 10, 2009 John H. Hammergren Chairman and Chief Executive Officer Safe Harbor Clause Some of the information in this presentation may constitute forwardlooking
More informationWilliam Blair Growth Conference Tom Richards. Chairman & CEO CDW Corporation
William Blair Growth Conference 2015 Tom Richards Chairman & CEO 2012 CDW Corporation Disclaimers This presentation contains forward-looking statements within the meaning of the federal securities laws.
More informationINVESTOR PRESENTATION. Fall 2017
INVESTOR PRESENTATION Fall 2017 DISCLAIMERS Forward-Looking Statements Statements in this document that are not statements of historical fact are forward-looking statements within the meaning of the safe
More informationAvery Dennison. Jefferies Industrials Conference August 9, Cindy Guenther VP Investor Relations and Treasury
Avery Dennison Jefferies Industrials Conference August 9, 2018 Cindy Guenther VP Investor Relations and Treasury 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking
More informationDENTSPLY International Inc.
March 18, 2015 DENTSPLY International Inc. Current Recommendation Prior Recommendation NEUTRAL Outperform Date of Last Change 02/19/2012 Current Price (03/17/15) $51.13 Target Price $54.00 SUMMARY (XRAY-NASDAQ)
More informationCorporate Presentation. November 2018
Corporate Presentation November 2018 1 Safe Harbor / Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time to time make, "forward-looking statements"
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationESTABLISHING A GLOBAL LEADER IN WORKWEAR 1. August 14, 2017
ESTABLISHING A GLOBAL LEADER IN WORKWEAR 1 August 14, 2017 FORWARD-LOOKING STATEMENTS Certain statements included in this presentation are "forward-looking statements" within the meaning of the federal
More informationEarnings Presentation 2nd Quarter 2017
Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationTENNANT COMPANY INVESTOR PRESENTATION REINVENTING HOW THE WORLD CLEANS
INVESTOR PRESENTATION REINVENTING HOW THE WORLD CLEANS 2 Safe Harbor Statement This presentation contains certain statements that are considered forward-looking statements within the meaning of the Private
More informationRent-A-Center today is
INVESTOR PRESENTATION FIRST QUARTER 2014 Safe Harbor This presentation contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements generally can be identified
More informationAvery Dennison. Baird 2018 Global Industrial Conference. Mitch Butier President and Chief Executive Officer. November 8, 2018
Avery Dennison November 8, 2018 Mitch Butier President and Chief Executive Officer 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking statements" intended to
More informationRAYMOND JAMES TECHNOLOGY INVESTORS CONFERENCE DECEMBER 6, 2016
RAYMOND JAMES TECHNOLOGY INVESTORS CONFERENCE DECEMBER 6, 2016 SAFE HARBOR AND NON-GAAP Safe Harbor Statement This presentation contains certain comments that are forward-looking statements, including
More informationAllegion Second-Quarter 2016 Results. July 28, 2016
Allegion Second-Quarter 2016 Results July 28, 2016 Safe Harbor This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including
More informationQ Financial Results
Q2 2017 Financial Results July 26, 2017 Copyright Fortinet Inc. All rights reserved. Safe Harbor Statement Information, statements and projections contained in these presentation slides and related conference
More informationCIGNA CORPORATION INVESTOR PRESENTATION. May 5, Cigna
CIGNA CORPORATION INVESTOR PRESENTATION May 5, 2017 1 Forward looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
More informationPERFORMANCE AND TRAJECTORY
PERFORMANCE AND TRAJECTORY José (Joe) E. Almeida Chairman, President and CEO May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results,
More informationIDEXX Laboratories Announces First Quarter Results
FOR IMMEDIATE RELEASE Contact: Kerry Bennett, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results Reports revenue growth of 11% on both a reported and organic basis, driven
More informationDave Carlucci Chairman and CEO IMS Health
Dave Carlucci Chairman and CEO IMS Health 1 March 11, 2009 Safe Harbor Certain statements we make today are forward-looking within the meaning of the US federal securities laws. These statements include,
More information901 S. Central Expressway, Richardson, TX 75080
901 S. Central Expressway, Richardson, TX 75080 FOSSIL GROUP REPORTS THIRD QUARTER RESULTS Net Sales Increase 18% to $810 Million Diluted EPS Increases 25% to $1.58 Maintains Full Year EPS Guidance and
More informationIDEXX Laboratories Announces Third Quarter Results
FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Third Quarter Results Delivers 11% normalized organic revenue growth and $1.05 Adjusted
More informationB. Riley FBR s Annual Consumer & Media Conference
B. Riley FBR s Annual Consumer & Media Conference October 4, 2018 Joseph C. Bartolacci President and Chief Executive Officer Steven F. Nicola Chief Financial Officer 2018 Matthews International Corporation.
More informationEarnings Presentation 3rd Quarter, 2018
Earnings Presentation 3rd Quarter, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More informationFOSSIL GROUP, INC. REPORTS FIRST QUARTER FISCAL 2015 RESULTS; First Quarter Net Sales of $725 Million; Diluted EPS of $0.75
FOSSIL GROUP, INC. REPORTS FIRST QUARTER FISCAL 2015 RESULTS; First Quarter Net Sales of $725 Million; Diluted EPS of $0.75 Maintains Full Year Constant Currency Guidance and Provides Second Quarter Guidance
More informationQ Financial Results
Q4 2016 Financial Results February 2, 2017 Copyright Fortinet Inc. All rights reserved. Safe Harbor Statement Information, statements and projections contained in these presentation slides and related
More informationStrategy and Performance Overview. Please refer to for a reconciliation of non-gaap financial measures.
Strategy and Performance Overview Please refer to www.lowes.com/investor for a reconciliation of non-gaap financial measures. EXECUTIVE SUMMARY Attractive Market Broad Customer Base Diverse Product Offering
More informationHealthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer
Healthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer 25th Annual Credit Suisse Healthcare Conference Tuesday, November 8th Copyright 2016, Cardinal Health,
More informationMagellan Health: Innovating for Profitable Growth. Jefferies 2015 Healthcare Conference June 2, 2015
Magellan Health: Innovating for Profitable Growth Jefferies 2015 Healthcare Conference June 2, 2015 Cautionary Statement The schedules and statements made in this presentation include forward-looking statements
More informationZimmer Biomet Reports Second Quarter 2016 Financial Results
July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted
More informationIDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationOur Transformation Continues Sidoti NDR May 29-30, 2018
Our Transformation Continues Sidoti NDR May 29-30, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation,
More informationIDEXX Laboratories Announces First Quarter Results
FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX), today
More informationCIGNA GLOBAL SUPPLEMENTAL BENEFITS
CIGNA GLOBAL SUPPLEMENTAL BENEFITS As of February, 2016 1 Forward looking statements and non-gaap measures CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION
More informationAcquisition of Astra Tech June 22, 2011 NASDAQ-XRAY
Acquisition of Astra Tech June 22, 2011 1 Forward Looking Statements This presentation, in addition to historical information, contains forward-looking statements (as defined in the Securities Litigation
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationFinancial Results Q2 2016
Financial Results Q2 2016 Align Technology, Inc Q2 2016 Financial Results Conference Call Speakers: Joe Hogan, President and CEO David White, CFO Shirley Stacy, VP, Corporate Communications & Investor
More informationEarnings Presentation 4th Quarter, 2017
Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationIDEXX Laboratories Announces Second Quarter Results
FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Catalyst instrument placements at all-time record level of over
More informationAllegion Fourth-Quarter 2017 Results. February 20, 2018
Allegion Fourth-Quarter 2017 Results February 20, 2018 Safe Harbor This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including
More informationCopyright 2014 HomeAway Inc.
Copyright 2014 HomeAway Inc. Safe harbor statement This presentation contains "forward-looking" statements, subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995,
More informationSecond Quarter 2018 Financial Review and Analysis (preliminary, unaudited)
Second Quarter 2018 Financial Review and Analysis (preliminary, unaudited) Supplemental Presentation Materials Unless otherwise indicated, comparisons are to the same period in the prior year. 1 Second
More informationACI Worldwide (ACIW) Investor Conferences
ACI Worldwide (ACIW) Investor Conferences Spring/Summer 2014 Private Securities Litigation Reform Act of 1995 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements
More informationWESCO International John Engel Chairman, President and CEO. William Blair & Company 36 th Annual Growth Stock Conference June 14, 2016
WESCO International John Engel Chairman, President and CEO William Blair & Company 36 th Annual Growth Stock Conference June 14, 2016 Safe Harbor Statement Note: All statements made herein that are not
More informationINVESTOR PRESENTATION MAY 2017
INVESTOR PRESENTATION MAY 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking
More informationOwens & Minor Reports 3rd Quarter 2017 Financial Results
November 1, 2017 Owens & Minor Reports 3rd Quarter 2017 Financial Results Owens & Minor to acquire the Surgical & Infection Prevention Business of Halyard Health in a $710 million transaction RICHMOND,
More informationCIGNA CORPORATION. 37 th Annual J.P. Morgan Healthcare Conference January 7, David Cordani President and Chief Executive Officer
CIGNA CORPORATION 37 th Annual J.P. Morgan Healthcare Conference January 7, 2019 David Cordani President and Chief Executive Officer 2 Forward-looking statements and Non-GAAP measures CAUTIONARY STATEMENT
More informationIDEXX Laboratories Announces Second Quarter Results
FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX) (otherwise
More informationDentsply Sirona JP Morgan Healthcare Conference. January 9, 2019
Dentsply Sirona JP Morgan Healthcare Conference January 9, 2019 Forward-Looking Statements and Associated Risks Information the Company has included or incorporated by reference in this presentation, and
More informationFourth Quarter and Full Year 2018 Financial Review and Analysis
Fourth Quarter and Full Year 2018 Financial Review and Analysis (preliminary, unaudited) Supplemental Presentation Materials Unless otherwise indicated, comparisons are to the same periods in the prior
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION April 30, 2015 Safe Harbor Forward-Looking Statements. This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of
More informationNEW REVENUE ACCOUNTING STANDARD (ASC 606) February 7, 2018
NEW REVENUE ACCOUNTING STANDARD February 7, 2018 DISCLAIMERS Forward-Looking Statements Statements in this document that are not statements of historical fact are forward-looking statements within the
More information+ September 12, 2017
+ September 12, 2017 Safe Harbor Statement CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements with respect to the financial condition, results
More informationFirst Quarter 2018 Financial Review and Analysis (preliminary, unaudited)
First Quarter 2018 Financial Review and Analysis (preliminary, unaudited) Supplemental Presentation Materials Unless otherwise indicated, comparisons are to the same period in the prior year. 1 First Quarter
More informationAvery Dennison Jefferies Industrials Conference
Avery Dennison Jefferies Industrials Conference August 9, 2016 Anne Bramman SVP and Chief Financial Officer 1 Avery Dennison Investor Presentation Forward-Looking Statements Certain statements contained
More informationInvestor Presentation. William Blair Growth Stock Conference June 12, 2018
Investor Presentation William Blair Growth Stock Conference June 12, 2018 Safe Harbor Statement This Presentation contains or incorporates by reference statements that are not historical in nature and
More informationDecember Colliers International Group Inc. Investor Presentation
December 2018 Colliers International Group Inc. Investor Presentation Basis Of Presentation All amounts in millions of US Dollars unless otherwise noted. Adjusted EBITDA ( AEBITDA ) and Adjusted EPS (
More informationSeptember Colliers International Group Inc. Investor Presentation
September 2018 Colliers International Group Inc. Investor Presentation Basis Of Presentation All amounts in millions of US Dollars unless otherwise noted. Adjusted EBITDA ( AEBITDA ) and Adjusted EPS (
More informationInvestor Presentation. March 2016
Investor Presentation March 2016 Safe Harbor Statement This presentation includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation
More informationIngersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019
Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019 1 Safe Harbor This presentation contains forward-looking statements, which are statements that are not historical facts, including
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference June 7, 2017 Disclaimer Certain statements in this presentation and other oral or written statements made by the Company from time to time are may constitute forward-looking
More informationQ4 FY18 Financial Update
Q4 FY8 Financial Update Salesforce NYSE: CRM @Salesforce_ir Safe Harbor "Safe harbor" statement under the Private Securities Litigation Reform Act of 995: This presentation contains forward-looking statements
More informationIDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationJefferies Consumer Summit 2018
Jefferies Consumer Summit 2018 FORWARD LOOKING STATEMENTS Statements made in this presentation that look forward in time or that express management s beliefs, expectations or hopes are forward-looking
More informationStericycle Investor Presentation Q NASDAQ: SRCL
Stericycle Investor Presentation Q3-2017 NASDAQ: SRCL Forward - Looking Statements Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties,
More informationACI Worldwide (ACIW) May/June 2015
ACI Worldwide (ACIW) May/June 2015 Private Securities Litigation Reform Act of 1995 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements based on current expectations
More informationPolycom Announces Financial Results for First Quarter 2016
Investor Contact: Press Contact: Laura Graves Polycom, Inc. 1.408.586.4271 laura.graves@polycom.com Cameron Craig Polycom, Inc. 1.408.586.3776 cameron.craig@polycom.com Polycom Announces Financial Results
More informationForward-Looking Statements
March 2006 0 Forward-Looking Statements This presentation contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are outside our control. These forward-looking
More informationWESCO International John Engel Chairman, President and CEO
WESCO International John Engel Chairman, President and CEO Raymond James 37 th Annual Institutional Investors Conference 2016 Raymond James 37th Annual Institutional Investors Conference 2016 Safe Harbor
More informationSabrina Simmons. Executive Vice President and Chief Financial Officer
Sabrina Simmons Executive Vice President and Chief Financial Officer Disclosure Statement Forward-Looking Statements This presentation contains forward-looking statements within the "safe harbor" provisions
More informationCDW. Investor Presentation. Winter/Spring 2019
CDW Investor Presentation Winter/Spring 2019 DISCLAIMERS Forward-Looking Statements This presentation contains forward-looking statements, which are any predications, projections, or other statements about
More informationThe IDEXX Opportunity
The IDEXX Opportunity 1 2018 IDEXX Laboratories, Inc. All rights reserved. Brian McKeon, Executive Vice President and CFO Bank of America Merrill Lynch Global Healthcare Conference London I September 12,
More informationJohn Engel Chairman, President and CEO. EPG Conference May 19, 2014
John Engel Chairman, President and CEO EPG Conference May 19, 2014 Safe Harbor Statement Note: All statements made herein that are not historical facts should be considered as forwardlooking statements
More informationFinancial Results Q Align Technology, Inc.
Financial Results Q1 2017 Align Technology, Inc. ALIGN 2017 TECHNOLOGY, ALIGN TECHNOLOGY, INC INC 1 Align Technology, Inc Q1 2017 Financial Results Conference Call Speakers: - Joe Hogan, President and
More informationCIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016 o o o
More informationInvestor Presentation November Products. Technology. Services. Delivered Globally.
Investor Presentation November 2018 Products. Technology. Services. Delivered Globally. Safe Harbor Statement and Non-GAAP Financial Measures Safe Harbor Statement The statements in this release other
More informationEGP 2.9 BN 51.1% y-o-y. EGP 216 MN 44.9% y-o-y. EGP 92 MN 69.4% y-o-y. EGP 28 MN 46.3% y-o-y. EGP 36 MN 88.4% y-o-y.
EARNINGS RELEASE Ibnsina Pharma Releases Audited Results Ibnsina Pharma starts 2018 off strong with year-on-year revenue and EBITDA growth of 51% and 69% respectively in 1Q2018, ensuring a sustained growth
More informationJP Morgan Healthcare Conference January 13, 2016
JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of
More informationXylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016
1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.
More informationACI Worldwide (ACIW) BAML 2014 Leveraged Finance Conference
ACI Worldwide (ACIW) BAML 2014 Leveraged Finance Conference December 2014 Private Securities Litigation Reform Act of 1995 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking
More informationFirst Quarter Fiscal 2018 Earnings
First Quarter Fiscal 2018 Earnings Prepared Management Remarks November 9, 2017 Investor Relations Contact: Laura Kiernan Senior Vice President, Investor Relations Laura.Kiernan@ubnt.com NASDAQ: UBNT Ubiquiti
More informationSYSCO REPORTS THIRD QUARTER EARNINGS
SYSCO REPORTS THIRD QUARTER EARNINGS HOUSTON, May 7, 2018 - Sysco Corporation (NYSE: SYY) today announced financial results for its 13-week third fiscal quarter ended March 31, 2018. Third Quarter Fiscal
More informationWESCO International John Engel Chairman, President and CEO. EPG Conference May 16, 2016
WESCO International John Engel Chairman, President and CEO Safe Harbor Statement Note: All statements made herein that are not historical facts should be considered as forwardlooking statements within
More information